tiprankstipranks

Murphy Sean Insider Profile

4 Followers
Murphy Sean, Director, Ten Percent Owner at Poseida Therapeutics, holds 9.20M shares in Poseida Therapeutics (Ticker: PSTX), holds ― shares in Radius Health (Ticker: RDUS). Most recently, Murphy Sean Bought ― shares of Poseida Therapeutics on Jul 15, 2020 for an estimated value of 160.00K.
tipranks
Murphy Sean

Murphy Sean
Poseida Therapeutics (PSTX)
Director, Ten Percent Owner

Not Ranked
Murphy Sean has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$107M
100.00%
0.00%
A breakdown of Murphy Sean's holdings

Insider Roles

Poseida Therapeutics
(PSTX)
Director, Ten Percent Owner
Radius Health
(RDUS)
Director
Roles that Murphy Sean holds in companies

Most Profitable Insider Trade

Stock:
Poseida Therapeutics
(PSTX)
Rating:Informative Buy
Date:Jul 15, 2020 - Jul 15, 2021
Return:-17.20%
The most profitable trade made by Murphy Sean

Murphy Sean's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Poseida Therapeutics
Jul 15, 2020
Director, Ten Percent Owner
Informative Buy
160.00K
$106.70M
Radius Health
Director
List of latest transactions for each holding click on a transaction to see Murphy Sean's performance on stock

Murphy Sean insider profile FAQ

What is the percentage of profitable transactions made by Murphy Sean?
The percentage of profitable transactions made by Murphy Sean is ―.
    What is the average return per transaction made by Murphy Sean?
    The average return per transaction made by Murphy Sean is ―.
      What stocks does Murphy Sean hold?
      Murphy Sean holds: PSTX, RDUS stocks.
        What was Murphy Sean’s latest transaction?
        Murphy Sean latest transaction was an Informative Buy of $160.00K.
          What was Murphy Sean's most profitable transaction?
          Murphy Sean’s most profitable transaction was an Informative Buy of PSTX stock on July 15, 2020. The return on the trade was -17.20%.
            What is Murphy Sean's role in Poseida Therapeutics?
            Murphy Sean's role in Poseida Therapeutics is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.